D-0589-2016 Class II Terminated

Recalled by Pharmakon Pharmaceuticals — Noblesville, IN

FDA drug recall D-0589-2016 was initiated by Pharmakon Pharmaceuticals on Aug 19, 2015 and is designated Class II. Reason for recall: Subpotent drug. The recall status is terminated (terminated May 9, 2017). Affected quantity: 1150.

Recall Details

Product Type
Drugs
Report Date
Feb 3, 2016
Initiation Date
Aug 19, 2015
Termination Date
May 9, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1150

Product Description

Epinephrine (PF) 10 mcg/mL in 0.9% Sodium Chloride, injectable packed in syringes, Total dosage 50 mg/ 5mL, Rx only, PHARMAKON Pharmaceuticals, Inc.

Reason for Recall

Subpotent drug.

Distribution Pattern

Nationwide

Code Information

All lots with expiration dates up to 11/17/2015

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0589-2016
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 26, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.